Axsome Therapeutics
AXSM
AXSM
173 hedge funds and large institutions have $827M invested in Axsome Therapeutics in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 66 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more capital invested
Capital invested by funds: $791M → $827M (+$35.5M)
0% more funds holding
Funds holding: 173 → 173 (0)
4% less call options, than puts
Call options by funds: $106M | Put options by funds: $110M
Holders
173
Holding in Top 10
4
Calls
$106M
Puts
$110M
Top Buyers
| 1 | +$52.1M | |
| 2 | +$13.3M | |
| 3 | +$12.6M | |
| 4 |
Goldman Sachs
New York
|
+$12.2M |
| 5 |
US Bancorp
Minneapolis,
Minnesota
|
+$9.99M |
Top Sellers
| 1 | -$29.4M | |
| 2 | -$25.3M | |
| 3 | -$9.7M | |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$6.52M |
| 5 |
D.E. Shaw & Co
New York
|
-$5.69M |